Market Closed -
Bombay S.E.
06:10:13 2024-06-07 am EDT
|
5-day change
|
1st Jan Change
|
342
INR
|
+1.15%
|
|
+2.67%
|
+10.52%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
49,036
|
12,376
|
17,471
|
31,150
|
37,801
|
148,591
|
Enterprise Value (EV)
1 |
53,661
|
17,085
|
23,400
|
34,383
|
44,094
|
152,433
|
P/E ratio
|
15.1
x
|
6.02
x
|
36.9
x
|
76.1
x
|
17
x
|
32.9
x
|
Yield
|
0.13%
|
0.51%
|
0.36%
|
0.27%
|
0.29%
|
0.17%
|
Capitalization / Revenue
|
2.02
x
|
0.68
x
|
1.04
x
|
1.12
x
|
0.91
x
|
3.55
x
|
EV / Revenue
|
2.22
x
|
0.94
x
|
1.39
x
|
1.23
x
|
1.06
x
|
3.64
x
|
EV / EBITDA
|
9.55
x
|
5.77
x
|
18.3
x
|
21.7
x
|
10.6
x
|
24.1
x
|
EV / FCF
|
40.1
x
|
-85.3
x
|
-18.5
x
|
11.2
x
|
-7.68
x
|
196
x
|
FCF Yield
|
2.49%
|
-1.17%
|
-5.41%
|
8.89%
|
-13%
|
0.51%
|
Price to Book
|
3.01
x
|
0.71
x
|
0.97
x
|
1.67
x
|
1.66
x
|
4.88
x
|
Nbr of stocks (in thousands)
|
418,579
|
418,808
|
418,965
|
418,965
|
432,707
|
492,595
|
Reference price
2 |
117.2
|
29.55
|
41.70
|
74.35
|
87.36
|
301.6
|
Announcement Date
|
5/28/19
|
9/2/20
|
9/2/21
|
9/5/22
|
5/29/23
|
5/28/24
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
24,224
|
18,106
|
16,795
|
27,913
|
41,718
|
41,849
|
EBITDA
1 |
5,620
|
2,962
|
1,276
|
1,583
|
4,148
|
6,322
|
EBIT
1 |
5,281
|
2,605
|
848.2
|
1,142
|
3,690
|
5,857
|
Operating Margin
|
21.8%
|
14.39%
|
5.05%
|
4.09%
|
8.85%
|
14%
|
Earnings before Tax (EBT)
1 |
4,621
|
1,941
|
645.6
|
534.7
|
2,802
|
5,739
|
Net income
1 |
3,243
|
2,055
|
474.8
|
409.5
|
2,160
|
4,108
|
Net margin
|
13.39%
|
11.35%
|
2.83%
|
1.47%
|
5.18%
|
9.82%
|
EPS
2 |
7.740
|
4.908
|
1.130
|
0.9773
|
5.130
|
9.160
|
Free Cash Flow
1 |
1,338
|
-200.3
|
-1,266
|
3,057
|
-5,745
|
777.2
|
FCF margin
|
5.52%
|
-1.11%
|
-7.54%
|
10.95%
|
-13.77%
|
1.86%
|
FCF Conversion (EBITDA)
|
23.8%
|
-
|
-
|
193.14%
|
-
|
12.29%
|
FCF Conversion (Net income)
|
41.25%
|
-
|
-
|
746.6%
|
-
|
18.92%
|
Dividend per Share
2 |
0.1500
|
0.1500
|
0.1500
|
0.2000
|
0.2500
|
0.5000
|
Announcement Date
|
5/28/19
|
9/2/20
|
9/2/21
|
9/5/22
|
5/29/23
|
5/28/24
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
4,624
|
4,709
|
5,929
|
3,233
|
6,293
|
3,842
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8227
x
|
1.59
x
|
4.647
x
|
2.042
x
|
1.517
x
|
0.6077
x
|
Free Cash Flow
1 |
1,338
|
-200
|
-1,266
|
3,057
|
-5,745
|
777
|
ROE (net income / shareholders' equity)
|
21.3%
|
12.2%
|
2.68%
|
2.14%
|
10.4%
|
15.4%
|
ROA (Net income/ Total Assets)
|
12.7%
|
6.09%
|
1.98%
|
2.29%
|
6.47%
|
9.01%
|
Assets
1 |
25,566
|
33,763
|
23,975
|
17,910
|
33,391
|
45,595
|
Book Value Per Share
2 |
39.00
|
41.40
|
42.80
|
44.60
|
52.70
|
61.80
|
Cash Flow per Share
2 |
0.3400
|
1.000
|
1.260
|
4.140
|
4.800
|
4.360
|
Capex
1 |
2,038
|
2,467
|
350
|
232
|
825
|
524
|
Capex / Sales
|
8.41%
|
13.63%
|
2.08%
|
0.83%
|
1.98%
|
1.25%
|
Announcement Date
|
5/28/19
|
9/2/20
|
9/2/21
|
9/5/22
|
5/29/23
|
5/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +10.52% | 2.02B | | +20.59% | 68.31B | | -1.02% | 48.49B | | +23.82% | 44.42B | | +30.26% | 28.29B | | +7.56% | 19.12B | | +10.55% | 16.64B | | -5.73% | 16B | | -21.45% | 15.84B | | -20.45% | 13.51B |
Other Specialty Chemicals
|